Vox Sanguinis

Tibor J. Greenwalt; in memoriam
pp. 183-185(3)

Variant Creutzfeldt–Jakob disease transmission by plasma products: assessing and communicating risk in an era of scientific uncertainty
pp. 186-192(7)
Authors: Farrugia, A.; Ironside, J. W.; Giangrande, P.

Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection
pp. 193-200(8)
Authors: Koppelman, M. H. G. M.; Sjerps, M. C.; Reesink, H. W.; Cuypers, H. T. M.

Performance of ORTHO® HCV core antigen and trak-C™ assays for detection of viraemia in pre-seroconversion plasma and whole blood donors
pp. 201-207(7)
Authors: Tobler, L. H.; Stramer, S. L.; Lee, S. R.; Baggett, D.; Wright, D.; Hirschkorn, D.; Walsh, I.; Busch, M. P.

Optimal sampling time after preparation of platelet concentrates for detection of bacterial contamination by quantitative real-time polymerase chain reaction
pp. 208-214(7)
Authors: Mohammadi, T.; Pietersz, R. N. I.; Scholtalbers, L. A. H.; Vandenbroucke-Grauls, C. M. J. E.; Savelkoul, P. H. M.; Reesink, H. W.

Comparison of X-ray vs. gamma irradiation of CPDA-1 red cells
pp. 215-219(5)
Authors: Janatpour, K.; Denning, L.; Nelson, K.; Betlach, B.; MacKenzie, M.; Holland, P.

In-vitro evaluation of the PALL Leukotrap Affinity Prion Reduction Filter as a secondary device following primary leucoreduction
pp. 220-228(9)
Authors: Saunders, C.; Herbert, P.; Rowe, G.; Hayward, M.; Wilkins, K.; Milligan, J.; Stenning, M.; Seacombe, A.; Prowse, C.

Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors
pp. 229-235(7)
Authors: Suzuya, H.; Watanabe, T.; Nakagawa, R.; Watanabe, H.; Okamoto, Y.; Onishi, T.; Abe, T.; Kawano, Y.; Kagami, S.; Takaue, Y.

Motivation, recruitment and retention of voluntary non-remunerated blood donors: a survey-based questionnaire study
pp. 236-244(9)
Authors: Misje, A. H.; Bosnes, V.; Gåsdal, O.; Heier, H. E.

Blood inventory management in the type and screen era
pp. 245-250(6)
Author: Pereira, A.

Molecular genetic analysis for Ax phenotype of the ABO blood group system in Chinese
pp. 251-256(6)
Authors: Deng, Z. H.; Yu, Q.; Wu, G. G.; Lian, Y. L.; Su, Y. Q.; Li, D. C.; Wang, D. M.; Zhang, S. Y.

Severe thrombocytopenia due to host-derived anti-HPA-1a after non-myeloablative allogeneic haematopoietic stem cell transplantation for multiple myeloma: a case report
pp. 257-260(4)
Authors: Macher, S.; Schallmoser, K.; Staber, P. B.; Neumeister, P.; Posch, U.; Lanzer, G.; Panzer, S.

Light chain phenotypes of HLA antibodies in cases with suspected neonatal alloimmune thrombocytopenia
pp. 261-264(4)
Authors: Panzer, S.; Mayr, W. R.; Eichelberger, B.

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Japan
pp. 265-265(1)
Authors: Yugi, H.; Hino, S.; Satake, M.; Tadodoro, K.

HCV and HIV-1 donor screening using nucleic acid amplification technique (NAT)
pp. 266-266(1)
Authors: O'Riordan, J.; Williams, P.; Donnellan, J.

Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology in Poland
pp. 267-268(2)
Author: Brojer, E.

Jean Julliard Prize 2006
pp. 269-269(1)

Cellular Therapy Coding and Labeling Advisory Group
pp. 270-270(1)

CORRIGENDUM
pp. 271-271(1)

DIARY OF EVENTS
pp. 272-272(1)

Author index
pp. 273-274(2)

Subject index
pp. 275-276(2)